68 Ga-PSMA PET/CT Identifies "Pseudo-progression" of Bone Lesions in Prostate Cancer Observed on 68 Ga-DOTA-IBA PET/CT.
We report a case where 68 Ga-PSMA PET/CT distinguished "pseudo-progression" from progression observed on 68 Ga-DOTA-IBA PET/CT.
APA
Huang D, Zhang N, et al. (2026). 68 Ga-PSMA PET/CT Identifies "Pseudo-progression" of Bone Lesions in Prostate Cancer Observed on 68 Ga-DOTA-IBA PET/CT.. Clinical nuclear medicine, 51(1), 87-89. https://doi.org/10.1097/RLU.0000000000006085
MLA
Huang D, et al.. "68 Ga-PSMA PET/CT Identifies "Pseudo-progression" of Bone Lesions in Prostate Cancer Observed on 68 Ga-DOTA-IBA PET/CT.." Clinical nuclear medicine, vol. 51, no. 1, 2026, pp. 87-89.
PMID
40762993
Abstract
We report a case where 68 Ga-PSMA PET/CT distinguished "pseudo-progression" from progression observed on 68 Ga-DOTA-IBA PET/CT. In a 75-year-old man with metastatic castration-resistant prostate cancer (mCRPC), 68 Ga-DOTA-IBA PET/CT revealed markedly increased tracer uptake in bone metastases compared with pretreatment imaging, suggesting radiologic progression. However, 68 Ga-PSMA-11 PET/CT images demonstrated the complete metabolic response (PERCIST 1.0), revealing "pseudo-progression" of bone lesions in 68 Ga-DOTA-IBA, especially when combined with clinical symptoms, PSA, and ALP levels.
MeSH Terms
Humans; Male; Aged; Positron Emission Tomography Computed Tomography; Bone Neoplasms; Prostatic Neoplasms; Disease Progression; Gallium Radioisotopes; Edetic Acid; Organometallic Compounds; Gallium Isotopes
같은 제1저자의 인용 많은 논문 (5)
- Cost-effectiveness of pembrolizumab plus chemotherapy vs cemiplimab plus chemotherapy for first-line metastatic non-small cell lung cancer: a US payer perspective using a matching-adjusted indirect comparison.
- Chemical tools for discriminating single nucleotide variants: from design principles to clinical applications.
- Metformin treatment and reduction of gastrointestinal cancer risk: A 2-sample Mendelian randomization study.
- Exempting axillary staging surgery in breast cancer using multimodal ultrasound imaging and radiomics of sentinel lymph nodes.
- MSI1 Accelerates Prostate Cancer Cell Proliferation, Migration and Glycolysis by Promoting ABHD2 Transcription.